Abstract:Objective: Schizophrenia patients often have personality disorders; schizophrenia patients with personality disorders are more difficult to treat and have a worse prognosis. Early identification of this group of patients and early intervention can achieve better prognosis. Therefore, it is very important to explore effective biomarkers and early diagnosis for the prognosis of schizophrenia. The primary purpose of this paper is to explore the relationship between plasma miRNA expression level and personality disorder with schizophrenia. Methods: Gene microarrays in miRNA files were employed, and the plasma of peripheral blood of 82 schizophrenic patients and 43 healthy control subjects were examined. Real-time reverse transcription polymerase chain reaction detection were performed to explore the results. Spearman correlation analysis was used to analyze the correlation between expression level of miRNAs and Personality Diagnosis Questionnaire-4 score. Results: The results showed that miR-1273d, miR-1303, miR-3064-5p, miR-3131, miR-3687, miR-4428, miR-4725-3p, and miR-5096 were up-regulated in schizophrenic patients. Compared to healthy control subjects, the difference was statistically significant (P < .05). Schizophrenic patients with schizoid, paranoid, schizotypal, and obsessive compulsive traits had negative correlation with miR-1303, miR-3131, miR-4428, and miR-5096 expression level (r = -0.40 to -0.62, P < .05); there were no significant differences in the other miRNAs. Correlation with other personality traits was not significant (P > .05). The stepwise regression analysis indicated that miR-5096, miR-3131, and miR-1273d have a significant predictive effect on the schizoid trait (P < .01). MiR-4428 and miR-1303 had a significant predictive effect on the schizotypal trait (P < .01). MiR-5096, miR-4428, and miR-4725-3P had a significant predictive effect on the paranoid trait (P < .05). MiR-4428, miR-1303, and miR-5096 had a significant predictive effect on the obsessive compulsive trait (P < .05). Conclusion: The expression levels of miR-1273d, miR-1303, miR-3064-5p, miR-3131, miR-3687, miR-4428, miR-4725-3p, and miR-5096 were up-regulated in the peripheral blood of patients with schizophrenia, and these miRNAs are expected to be diagnostic biomarkers for accurate diagnosis of schizophrenia. The expression levels of miR-1303, miR-3131, miR-1273d, miR-4428, miR-4725-3p, and miR-5096 have significant predictive effects on personality disorder in schizophrenia.

Deregulatory miRNA-BDNF Network Inferred from Dynamic Expression Changes in Schizophrenia

Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.

A Potential Immune-Related miRNAs Regulatory Network and Corresponding Diagnostic Efficacy in Schizophrenia

The Microrna-195 - BDNF Pathway and Cognitive Deficits in Schizophrenia Patients with Minimal Antipsychotic Medication Exposure

Associations Between Three Microrna Gene Polymorphisms and Schizophrenia Susceptibility in a Han Chinese Population.

A Novel Microrna and Transcription Factor Mediated Regulatory Network in Schizophrenia

Identification of Peripheral Blood Mirna Biomarkers in First-Episode Drug-Free Schizophrenia Patients Using Bioinformatics Strategy.

Genome-Wide, Integrative Analysis Implicates Exosome-Derived MicroRNA Dysregulation in Schizophrenia.

MicroRNA Schizophrenia: Etiology, Biomarkers and Therapeutic Targets

Relationship Between Schizophrenia and Changes in the Expression of the Long Non-Coding RNAs Meg3, Miat, Neat1 and Neat2.

Mirna-Coordinated Schizophrenia Risk Network Cross-Talk with Cardiovascular Repair and Opposed Gliomagenesis

Establishment of a Schizophrenia Classifier Based on Peripheral Blood Signatures and Investigation of Pathogenic Mirna-Mrna Regulation.

BDNF Gene's Role in Schizophrenia: From Risk Allele to Methylation Implications

MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients

CASCADE TF-MIRNA-MRNA REGULATIONS IDENTIFIED BY CO-EXPRESSION NETWORK MODULES IN BRAINS OF PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER

Converging evidence implicates the abnormal microRNA system in schizophrenia.

Exploration of Positive and Negative Schizophrenia Symptom Heterogeneity and Establishment of Symptom-Related miRNA-mRNA Regulatory Network: Based on Transcriptome Sequencing Data

The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia

A Potential Autophagy-Related Competing Endogenous RNA Network and Corresponding Diagnostic Efficacy in Schizophrenia

Diagnostic Value of Blood-Derived Micrornas for Schizophrenia: Results of a Meta-Analysis and Validation

MiRNAs of peripheral blood as the biomarker of schizophrenia